期刊
CANCER BIOLOGY & THERAPY
卷 19, 期 5, 页码 347-348出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/15384047.2018.1423926
关键词
androgen; Cancer Biology; castration; independent; medicine; personalized; receptor; resistance
类别
Androgen deprivation therapy remains the backbone of prostate cancer treatment given its pivotal role in the pathogenesis of prostate cancer. The growing knowledge of androgen receptor-independent (i.e. AR-null) prostate cancer cells, however, might advance the treatment paradigm of prostate cancer. Here, we examined the results of two recent studies, published in Cancer Cell by Bluemn and Shukla et al., and their impact in the future management of castration-resistant prostate cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据